Frailty Index Accurately Predicts Postoperative Complications After Prostate Surgery
- byDoctor News Daily Team
- 01 August, 2025
- 0 Comments
- 0 Mins
The Five-item Frailty Index (5i-FI) is a tool used by physicians to predict surgical risk and postoperative complications after a procedure. Researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, looked at whether the 5i-FI could be used to predict surgical complications in endoscopic surgery for benign prostatic obstruction (BPO).
Patients who received either transurethral resection of the prostate (TURP) between 2009 and 2019, photoselective vaporization of the prostate (PVP), or laser enucleation of the prostate (LEP) were assessed for frailty using the 5i-FI. The frailty scores were then compared against any complications experienced, major complications, length of stay in the hospital, and 30-day postoperative readmission. The team found that a 5i-FI score greater than two is predictive of these instances.
"The 5-item Frailty Index is an easy tool that predicts postoperative complications after endoscopic surgery for benign prostatic hyperplasia," said first author Muhieddine Labban, MD, of the Division of Urology and the Center for Surgery and Public Health.
"After weighting for patients' frailty scores and demographics, LEP and PVP were associated with lower odds of complications and shorter hospital stays. Nevertheless, both LEP and PVP are less likely to be used among men with higher frailty scores," said senior author Quoc‐Dien Trinh, MD, of the Brigham's Division of Urology and Center for Surgery and Public Health. "Preoperative frailty assessment using the 5i-FI could improve risk stratification."
Reference:
Labban, M., Frego, N., Qian, Z. et al. Does the 5-item Frailty Index predict surgical complications of endoscopic surgical management for benign prostatic obstruction? An analysis of the ACS-NSQIP. World J Urol (2022). https://doi.org/10.1007/s00345-022-04151-8
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!